Who owns IRulya Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of QNCX from SEC Form 13F filings across 26 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 26 institutions disclosed 330,050 shares of IRulya Therapeutics Inc. worth $17.3M — about 5.4% of shares outstanding; the largest disclosed holder is Ikarian Capital, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
26
13F holders
$17.3M
value, 2026 filers
5.4%
of shares outstanding (330,050 sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of QNCX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Ikarian Capital, LLCNEW | 72,251 | $1.3M | 0.1% | 1.2% | new |
| 2 | MILLENNIUM MANAGEMENT LLCNEW | 70,779 | $1.3M | 0.0% | 1.2% | new |
| 3 | Balyasny Asset Management L.P.NEW | 69,967 | $12.6M | 0.0% | 1.1% | new |
| 4 | Squadron Capital Management LLCNEW | 40,375 | $734,421 | 0.2% | 0.7% | new |
| 5 | Shay Capital LLCNEW | 17,468 | $329,272 | 0.0% | 0.3% | new |
| 6 | BOOTHBAY FUND MANAGEMENT, LLCNEW | 13,911 | $253,041 | 0.0% | 0.2% | new |
| 7 | JANE STREET GROUP, LLCNEW | 12,642 | $229,958 | 0.0% | 0.2% | new |
| 8 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 12,044 | $219,080 | 0.0% | 0.2% | new |
| 9 | Cormorant Asset Management, LPNEW | 5,498 | $100,009 | 0.0% | 0.1% | new |
| 10 | UBS Group AGNEW | 4,730 | $86,039 | 0.0% | 0.1% | new |
| 11 | MORGAN STANLEYNEW | 4,084 | $74,288 | 0.0% | 0.1% | new |
| 12 | VANGUARD FIDUCIARY TRUST CONEW | 3,614 | $65,739 | 0.0% | 0.1% | new |
| 13 | BlackRock, Inc.NEW | 1,702 | $30,959 | 0.0% | 0% | new |
| 14 | Tower Research Capital LLC (TRC)NEW | 567 | $10,314 | 0.0% | 0% | new |
| 15 | Gen-Wealth Partners IncNEW | 165 | $3,001 | 0.0% | 0% | new |
| 16 | Operose Advisors LLCNEW | 159 | $2,893 | 0.0% | 0% | new |
| 17 | Fortitude Family Office, LLCNEW | 40 | $728 | 0.0% | 0% | new |
| 18 | BARCLAYS PLCNEW | 27 | $491 | 0.0% | 0% | new |
| 19 | WELLS FARGO & COMPANY/MNNEW | 10 | $182 | 0.0% | 0% | new |
| 20 | Allworth Financial LPNEW | 8 | $137 | 0.0% | 0% | new |
| 21 | Parallel Advisors, LLCNEW | 3 | $55 | 0.0% | 0% | new |
| 22 | JPMORGAN CHASE & CONEW | 2 | $2 | 0.0% | 0% | new |
| 23 | Westside Investment Management, Inc.NEW | 1 | $18 | 0.0% | 0% | new |
| 24 | Steward Partners Investment Advisory, LLCNEW | 1 | $18 | 0.0% | 0% | new |
| 25 | ROYAL BANK OF CANADANEW | 1 | $0 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.